Move impurity and safety calls at the speed of a development program.

Drug programs run on tight timelines and heavy documentation: mutagenic-impurity control under ICH M7, safety assessment of intermediates and degradants, and read-across for compounds with thin data. ToxIndex runs those assessments reproducibly, so the paperwork keeps pace with the chemistry.

Updated July 18, 2026

ICH M7
impurity workflows, reproducible
100+
tools, including mutagenicity models
Air-gapped
deployment for sensitive pipelines

Where pharma teams lose time

Impurity assessments, intermediate safety, and degradant characterization all demand a defensible (Q)SAR read and an audit trail, all on a schedule that does not wait. Manual assessment is both the bottleneck and the reproducibility risk.

ToxIndex runs these as versioned workflows over predictors and OECD read-across, so an assessment reproduces exactly when an auditor asks, and a reviewer can interrogate any call in plain language.

Questions teams ask

Frequently asked questions

What pharma assessments does ToxIndex run?

Mutagenic-impurity control under ICH M7, structure-based safety for intermediates and degradants, and read-across for compounds with thin data — each as a reproducible, audit-trailed workflow.

Can we keep chemical structures inside our environment?

Yes. Single-tenant and on-prem deployments keep structures inside your own environment, air-gapped if a pipeline requires it.

How many tools are available?

100+ deployed tools, including bacterial mutagenicity models for the second (Q)SAR read ICH M7 requires.

See it on your own chemistry.

Try the free version now, or book a walkthrough of the full platform on your substances.